Steven H. Stein - 06 Nov 2026 Form 4 Insider Report for INCYTE CORP (INCY)

Reporting relationship: CMO & Head of Late-Stage Dev.
Issuer ticker: INCY
Reported as of: 06 Nov 2026
Net transaction value: -$28,435,748
SEC form: 4
Accepted by SEC: 10 Nov 2026, 16:07:23 UTC
Prior SEC filing: 20 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Elizabeth Feeney, Attorney-In-Fact

Filing notes and source

Key filing fact

Steven H. Stein filed Form 4 for INCYTE CORP (INCY) on 10 Nov 2026.

Key facts

This page summarizes Steven H. Stein's Form 4 filing for INCYTE CORP (INCY).
37 reported transactions and 16 derivative rows are listed below.
Accepted by SEC: 10 Nov 2026, 16:07.

Change

Previous filing in this sequence was filed on 20 Jul 2026.
Current net transaction value: -$28,435,748.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001673776 Primary reporting owner

Stein Steven H

Relationship: CMO & Head of Late-Stage Dev.
Address: 1801 AUGUSTINE CUT-OFF, WILMINGTON
Signature: /s/ Elizabeth Feeney, Attorney-In-Fact
Signature date: 10 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INCY transaction

Common Stock

Options Exercise

Transaction value
Shares: +8,539
Change %: +28%
Price: $68.62^*
Shares after: 39,455
Date: 06 Nov 2026
Ownership: Direct

INCY transaction

Common Stock

Options Exercise

Transaction value
Shares: +12,335
Change %: +31%
Price: $72.27^*
Shares after: 51,790
Date: 06 Nov 2026
Ownership: Direct

INCY transaction

Common Stock

Options Exercise

Transaction value
Shares: +16,428
Change %: +32%
Price: $80.50^*
Shares after: 68,218
Date: 06 Nov 2026
Ownership: Direct

INCY transaction

Common Stock

Options Exercise

Transaction value
Shares: +15,054
Change %: +22%
Price: $74.78^*
Shares after: 83,272
Date: 06 Nov 2026
Ownership: Direct

INCY transaction

Common Stock

Options Exercise

Transaction value
Shares: +23,526
Change %: +28%
Price: $77.67^*
Shares after: 106,798
Date: 06 Nov 2026
Ownership: Direct

INCY transaction

Common Stock

Options Exercise

Transaction value
Shares: +18,331
Change %: +17%
Price: $61.76^*
Shares after: 125,129
Date: 06 Nov 2026
Ownership: Direct

INCY transaction

Common Stock

Options Exercise

Transaction value
Shares: +19,749
Change %: +16%
Price: $61.18^*
Shares after: 144,878
Date: 06 Nov 2026
Ownership: Direct

INCY transaction

Common Stock

Options Exercise

Transaction value
Shares: +12,305
Change %: +8.5%
Price: $64.25^*
Shares after: 157,183
Date: 06 Nov 2026
Ownership: Direct

INCY transaction

Common Stock

Options Exercise

Transaction value
Shares: +6,907
Change %: +4.4%
Price: $68.25^*
Shares after: 164,090
Date: 06 Nov 2026
Ownership: Direct

INCY transaction

Common Stock

Options Exercise

Transaction value
Shares: +16,428
Change %: +10%
Price: $85.01^*
Shares after: 180,518
Date: 06 Nov 2026
Ownership: Direct

INCY transaction

Common Stock

Options Exercise

Transaction value
Shares: +12,743
Change %: +7.1%
Price: $90.56^*
Shares after: 193,261
Date: 06 Nov 2026
Ownership: Direct

INCY transaction

Common Stock

Options Exercise

Transaction value
Shares: +15,054
Change %: +7.8%
Price: $83.58^*
Shares after: 208,315
Date: 06 Nov 2026
Ownership: Direct

INCY transaction

Common Stock

Options Exercise

Transaction value
Shares: +24,838
Change %: +12%
Price: $83.20^*
Shares after: 233,153
Date: 06 Nov 2026
Ownership: Direct

INCY transaction

Common Stock

Options Exercise

Transaction value
Shares: +879
Change %: +0.38%
Price: $113.64^*
Shares after: 234,032
Date: 06 Nov 2026
Ownership: Direct

INCY transaction

Common Stock

Options Exercise

Transaction value
Shares: +17,986
Change %: +7.7%
Price: $113.64^*
Shares after: 252,018
Date: 06 Nov 2026
Ownership: Direct

INCY transaction

Common Stock

Options Exercise

Transaction value
Shares: +19,091
Change %: +7.6%
Price: $113.64^*
Shares after: 271,109
Date: 06 Nov 2026
Ownership: Direct

INCY transaction

Common Stock

Sale

Transaction value: -$4,067,087
Shares: -35,042
Change %: -13%
Price: $116.06
Shares after: 236,067
Date: 06 Nov 2026
Ownership: Direct
Footnotes: F1

INCY transaction

Common Stock

Sale

Transaction value: -$2,616,551
Shares: -22,336
Change %: -9.5%
Price: $117.14
Shares after: 213,731
Date: 06 Nov 2026
Ownership: Direct
Footnotes: F2

INCY transaction

Common Stock

Sale

Transaction value: -$7,128,308
Shares: -60,270
Change %: -28%
Price: $118.27
Shares after: 153,461
Date: 06 Nov 2026
Ownership: Direct
Footnotes: F3

INCY transaction

Common Stock

Sale

Transaction value: -$8,811,010
Shares: -73,969
Change %: -48%
Price: $119.12
Shares after: 79,492
Date: 06 Nov 2026
Ownership: Direct
Footnotes: F4

INCY transaction

Common Stock

Sale

Transaction value: -$5,812,794
Shares: -48,576
Change %: -61%
Price: $119.66
Shares after: 30,916
Date: 06 Nov 2026
Ownership: Direct
Footnotes: F5, F6

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INCY transaction Derivative

Employee Stock Option (right to buy)

Options Exercise

Transaction value
Shares: -8,539
Change %: -100%
Price: $0.000000^*
Shares after: 1
Date: 06 Nov 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,539
Exercise price: $68.62
Footnotes: F7

INCY transaction Derivative

Employee Stock Option (right to buy)

Options Exercise

Transaction value
Shares: -12,335
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 06 Nov 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 12,335
Exercise price: $72.27
Footnotes: F8

INCY transaction Derivative

Employee Stock Option (right to buy)

Options Exercise

Transaction value
Shares: -16,428
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 06 Nov 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 16,428
Exercise price: $80.50
Footnotes: F9

INCY transaction Derivative

Employee Stock Option (right to buy)

Options Exercise

Transaction value
Shares: -15,054
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 06 Nov 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 15,054
Exercise price: $74.78
Footnotes: F10

INCY transaction Derivative

Employee Stock Option (right to buy)

Options Exercise

Transaction value
Shares: -23,526
Change %: -92%
Price: $0.000000^*
Shares after: 2,139
Date: 06 Nov 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 23,526
Exercise price: $77.67
Footnotes: F11

INCY transaction Derivative

Employee Stock Option (right to buy)

Options Exercise

Transaction value
Shares: -18,331
Change %: -65%
Price: $0.000000^*
Shares after: 10,054
Date: 06 Nov 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 18,331
Exercise price: $61.76
Footnotes: F12

INCY transaction Derivative

Employee Stock Option (right to buy)

Options Exercise

Transaction value
Shares: -19,749
Change %: -65%
Price: $0.000000^*
Shares after: 10,831
Date: 06 Nov 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 19,749
Exercise price: $61.18
Footnotes: F13

INCY transaction Derivative

Employee Stock Option (right to buy)

Options Exercise

Transaction value
Shares: -12,305
Change %: -40%
Price: $0.000000^*
Shares after: 18,783
Date: 06 Nov 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 12,305
Exercise price: $64.25
Footnotes: F14

INCY transaction Derivative

Employee Stock Option (right to buy)

Options Exercise

Transaction value
Shares: -6,907
Change %: -25%
Price: $0.000000^*
Shares after: 20,722
Date: 06 Nov 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 6,907
Exercise price: $68.25
Footnotes: F15

INCY transaction Derivative

Employee Stock Option (right to buy)

Options Exercise

Transaction value
Shares: -16,428
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 06 Nov 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 16,428
Exercise price: $85.01
Footnotes: F16

INCY transaction Derivative

Employee Stock Option (right to buy)

Options Exercise

Transaction value
Shares: -12,743
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 06 Nov 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 12,743
Exercise price: $90.56
Footnotes: F17

INCY transaction Derivative

Employee Stock Option (right to buy)

Options Exercise

Transaction value
Shares: -15,054
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 06 Nov 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 15,054
Exercise price: $83.58
Footnotes: F18

INCY transaction Derivative

Employee Stock Option (right to buy)

Options Exercise

Transaction value
Shares: -24,838
Change %: -92%
Price: $0.000000^*
Shares after: 2,258
Date: 06 Nov 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 24,838
Exercise price: $83.20
Footnotes: F19

INCY transaction Derivative

Incentive Stock Option (right to buy)

Options Exercise

Transaction value
Shares: -879
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 06 Nov 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 879
Exercise price: $113.64
Footnotes: F20

INCY transaction Derivative

Non-Qualified Stock Option (right to buy)

Options Exercise

Transaction value
Shares: -17,986
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 06 Nov 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 17,986
Exercise price: $113.64
Footnotes: F20

INCY transaction Derivative

Non-Qualified Stock Option (right to buy)

Options Exercise

Transaction value
Shares: -19,091
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 06 Nov 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 19,091
Exercise price: $113.64
Footnotes: F21

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 21 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.56 to $116.55 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.64 to $117.63 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Footnote F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.64 to $118.635 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Footnote F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.64 to $119.63 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Footnote F5

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.65 to $119.79 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Footnote F6

This includes an aggregate of 29,338 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.

Footnote F7

Beginning July 2, 2018, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.

Footnote F8

Beginning January 4, 2019, options become exercisable in 37 installments, with the first 25.00% vesting on July 2, 2019 and the remainder vesting monthly over three years.

Footnote F9

Beginning January 17, 2020, options become exercisable in 37 installments, with the first 25.00% vesting on July 2, 2020 and the remainder vesting monthly over three years.

Footnote F10

Beginning January 19, 2022, options become exercisable in 37 installments, with the first 25.00% vesting on July 2, 2022 and the remainder vesting monthly over three years.

Footnote F11

Beginning July 2, 2022, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.

Footnote F12

The July 14, 2023 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.

Footnote F13

Beginning January 18, 2024, options become exercisable in 37 installments, with the first 25% vesting on July 14, 2024 and the remainder vesting monthly over three years.

Footnote F14

The July 15, 2024 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.

Footnote F15

The July 15, 2025 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.

Footnote F16

Beginning July 2, 2019, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.

Footnote F17

Beginning January 15, 2021, options become exercisable in 37 installments, with the first 25.00% vesting on July 2, 2021 and the remainder vesting monthly over three years.

Footnote F18

Beginning July 2, 2021, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.

Footnote F19

Beginning January 20, 2023, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2023 and the remainder vesting monthly over three years.

Footnote F20

Beginning January 17, 2017, options become exercisable in full on January 17, 2021.

Footnote F21

Beginning January 17, 2017, options become exercisable in 37 installments, with the first 25.00% vesting on July 15, 2017 and the remainder vesting monthly over three years.